Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma.

In conclusion, the present study demonstrated that RHPN2 may promote PDAC making it a potential candidate for targeted therapy. PMID: 33365087 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research